TAI · 6782.TW
Visco Vision Inc.
NT$264.00-NT$5.00 (-1.86%)
Visco Vision Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.0% below the high.
Loading market information…
TAI · 4736.TW · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
TaiDoc Technology Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.07% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
TaiDoc Technology Corporation’s forward annual dividend is NT$5.07 per share, paid annual. The forward yield is 3.87% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
TaiDoc Technology Corporation’s next earnings report is currently expected on Nov 11, 2026, with estimated earnings per share of NT$3.43. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow TaiDoc Technology Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
TaiDoc Technology Corporation, established in 1998 and based in New Taipei City, Taiwan, is a leading global producer and distributor of a wide array of medical devices. The company's comprehensive product catalog features advanced in vitro diagnostics, including multi-parameter monitoring systems, convenient point-of-care testing (POCT) devices, and precision lancet and lancing tools. For animal health, TaiDoc offers specialized veterinary diagnostics such as blood glucose, calcium, and ketone meters. Beyond diagnostics, their general medical equipment range encompasses vital devices like nebulizers, thermometers, blood pressure monitors, vital sign monitors, and pulse oximeters. In the connected health sector, they develop remote telehealth monitoring devices alongside user-friendly smartphone applications. The company also contributes to infectious disease screening, providing rapid antigen test kits for conditions like COVID-19. In addition to its product offerings, TaiDoc delivers value-added services, assisting clients with regulatory professional guidance, clinical consultation, engineering support, and sophisticated manufacturing system solutions. Furthermore, they offer a suite of proprietary software applications designed to enhance device functionality and user experience, such as MyLink, ProCheck, Healthy Check, Healthy Check PRO, PCLink, and a USB adapter driver.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:00 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| NT$976.79M-22.91% vs estimate |
| Q4 2024 | Mar 12, 2025 | NT$4.01+53.64% vs estimate | NT$1.17B-7.89% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | NT$1.03-61.42% vs estimate | NT$1.23B+0.41% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$264.00-NT$5.00 (-1.86%)
Visco Vision Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.0% below the high.
NT$48.85-NT$0.90 (-1.81%)
Medigen Vaccine Biologics Corp.’s quoted price sits in the lower half of its reported 52-week range, 32.34% below the high.
NT$72.90-NT$0.40 (-0.55%)
Excelsior Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.84% below the high.
NT$210.00-NT$2.00 (-0.94%)
Vizionfocus Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.19% below the high.
NT$75.00-NT$0.80 (-1.06%)
Foresee Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.96% below the high.
NT$56.70-NT$0.20 (-0.35%)
Standard Chem & Pharm Co. Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.36% below the high.
NT$129.50-NT$1.50 (-1.15%)
Universal Vision Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.57% below the high.
NT$58.20+NT$1.50 (+2.65%)
PharmaEngine, Inc.’s quoted price sits in the lower half of its reported 52-week range, 21.77% below the high.
